Nothing Special   »   [go: up one dir, main page]

AR045506A1 - Procedimiento de purificacion de terbinafina por destilacion. - Google Patents

Procedimiento de purificacion de terbinafina por destilacion.

Info

Publication number
AR045506A1
AR045506A1 ARP040103068A ARP040103068A AR045506A1 AR 045506 A1 AR045506 A1 AR 045506A1 AR P040103068 A ARP040103068 A AR P040103068A AR P040103068 A ARP040103068 A AR P040103068A AR 045506 A1 AR045506 A1 AR 045506A1
Authority
AR
Argentina
Prior art keywords
terbinafine
distillation
purification procedure
acid addition
addition salt
Prior art date
Application number
ARP040103068A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28686596&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR045506(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR045506A1 publication Critical patent/AR045506A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82—Purification; Separation; Stabilisation; Use of additives
    • C07C209/84—Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/30—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by two rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Se describe un procedimiento de purificación para la preparación de la terbinafina farmacéutica de alilamina de la fórmula (1), en la forma de base libre o en la forma de sal de adición de ácido, destilando la base de terbinafina cruda, preferiblemente a través de destilación de trayectoria corta, por ejemplo, a una temperatura por arriba de 100° C y presión reducida, por ejemplo, 0.2 mbarias, y recuperando el producto purificado en la forma de base libre o en la forma de sal de adición de ácido.
ARP040103068A 2003-08-29 2004-08-26 Procedimiento de purificacion de terbinafina por destilacion. AR045506A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0320312.2A GB0320312D0 (en) 2003-08-29 2003-08-29 Purification process

Publications (1)

Publication Number Publication Date
AR045506A1 true AR045506A1 (es) 2005-11-02

Family

ID=28686596

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040103068A AR045506A1 (es) 2003-08-29 2004-08-26 Procedimiento de purificacion de terbinafina por destilacion.

Country Status (25)

Country Link
US (2) US20060076227A1 (es)
EP (1) EP1694631A2 (es)
JP (1) JP5208416B2 (es)
KR (2) KR20120054109A (es)
CN (1) CN100491334C (es)
AR (1) AR045506A1 (es)
AU (1) AU2004268051B2 (es)
BR (1) BRPI0413896A (es)
CA (1) CA2536498C (es)
EC (1) ECSP066382A (es)
GB (1) GB0320312D0 (es)
IL (1) IL173709A (es)
IS (1) IS8369A (es)
MA (1) MA28030A1 (es)
MX (1) MXPA06002348A (es)
MY (1) MY149357A (es)
NO (1) NO20061404L (es)
NZ (1) NZ545445A (es)
PE (1) PE20050873A1 (es)
RU (1) RU2367649C2 (es)
SG (1) SG145782A1 (es)
TN (1) TNSN06066A1 (es)
TW (1) TWI350829B (es)
WO (1) WO2005021483A2 (es)
ZA (1) ZA200601264B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0503942D0 (en) * 2005-02-25 2005-04-06 Novartis Ag Purification process
EP1900378A1 (en) * 2006-08-31 2008-03-19 Novartis AG Pharmaceutical compositions for the treatment of fungal infections
WO2010027468A1 (en) 2008-09-05 2010-03-11 Travanti Pharma Inc. Iontophoretic drug delivery packaging

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000896B1 (en) * 1977-08-19 1982-10-13 Sandoz Ag Propenyl amines, processes for their production and pharmaceutical compositions containing them
DE19375084I2 (de) * 1979-08-22 2000-11-16 Novartis Ag Propenylamine Verfahren zu ihrer Herstellung sie enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung als Arzneimittel
US5132459A (en) * 1979-08-22 1992-07-21 Sandoz Ltd. Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
CH678527A5 (en) 1989-06-22 1991-09-30 Sandoz Ag Trans(E)-N-(1-naphthyl:methyl)-heptenyl-amine prepn. - by simultaneously converting crude mixt. contg. cis and trans isomers to salt and precipitating trans isomer
JP3116364B2 (ja) 1989-10-02 2000-12-11 萬有製薬株式会社 エンイン誘導体の製造法
NZ280065A (en) * 1995-09-20 1998-04-27 Apotex Inc Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
ES2203190T3 (es) 1999-10-22 2004-04-01 Richter Gedeon Vegyeszeti Gyar R.T. Procedimiento para la preparacion de (e)-n-metil-n-(1-naftil-metil)-6,6-dimetil-hept-2-en-4-inil-1-amina.
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
ITMI20010421A1 (it) * 2001-03-01 2002-09-02 Ausimont Spa Membrane porose semipermeabili di fluoropolimeri semicristallini
ITMI20010430A1 (it) * 2001-03-02 2002-09-02 Dinamite Dipharma S P A In For Metodo per la sintesi di terbinafina
KR100459275B1 (ko) * 2001-12-28 2004-12-03 주식회사유한양행 터비나핀 또는 그의 염산염의 제조방법
ITMI20022534A1 (it) * 2002-11-29 2004-05-30 Dinamite Dipharma S P A Procedimento per la preparazione di terbinafina mediante l'uso di platino come catalizzatore.
US20060004230A1 (en) * 2004-06-30 2006-01-05 Joseph Kaspi Process for the preparation of terbinafine and salts thereof

Also Published As

Publication number Publication date
US7985323B2 (en) 2011-07-26
IS8369A (is) 2006-03-23
RU2006109640A (ru) 2007-10-10
JP2007504110A (ja) 2007-03-01
KR101233024B1 (ko) 2013-02-13
CN100491334C (zh) 2009-05-27
MXPA06002348A (es) 2006-05-22
IL173709A (en) 2012-02-29
CA2536498C (en) 2012-10-09
WO2005021483A2 (en) 2005-03-10
TNSN06066A1 (en) 2007-10-03
GB0320312D0 (en) 2003-10-01
US20090216047A1 (en) 2009-08-27
EP1694631A2 (en) 2006-08-30
WO2005021483A3 (en) 2005-05-12
BRPI0413896A (pt) 2006-10-24
KR20120054109A (ko) 2012-05-29
JP5208416B2 (ja) 2013-06-12
ECSP066382A (es) 2006-09-18
TW200523231A (en) 2005-07-16
NZ545445A (en) 2010-03-26
NO20061404L (no) 2006-08-25
AU2004268051B2 (en) 2009-03-05
RU2367649C2 (ru) 2009-09-20
KR20060119892A (ko) 2006-11-24
MA28030A1 (fr) 2006-07-03
PE20050873A1 (es) 2005-11-21
MY149357A (en) 2013-08-30
SG145782A1 (en) 2008-09-29
CN1845895A (zh) 2006-10-11
ZA200601264B (en) 2007-06-27
AU2004268051A1 (en) 2005-03-10
IL173709A0 (en) 2006-07-05
CA2536498A1 (en) 2005-03-10
TWI350829B (en) 2011-10-21
US20060076227A1 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
BRPI0409109A (pt) novos compostos
DE502004004307D1 (de) Verfahren zur herstellung von gereinigten 1,3-substituierten imidazoliumsalzen
WO2001047877A3 (en) Process for the preparation of pure citalopram
BRPI0410685B8 (pt) processos de purificação do 1,3-propanodiol e composição
BRPI0500480A (pt) processo para a sìntese de (1s)-4,5-dimetóxi- 1-(metilaminometil)-benzociclobutano e sais de adição deste, e aplicação na sìntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável
NO20024772D0 (no) Percyquinnin, fremgangsmåte for dets fremstilling og dets anvendelse som et legemiddel
MX2007010403A (es) Proceso de purificacion.
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
NO20065942L (no) Gjenvinning av 2,6-naftalendiakarboksylsyre (2,6-NDA) inneholdt i polyetylennaftalat i en fremgangsmate for a fremstille diestere
MA29690B1 (fr) Procede de preparation de la 4beta-amino-4'-demethyl-4-desoxypodophyllotoxine
TNSN06066A1 (en) Process for the purification of terbinafine
BR0012631A (pt) Processo para a preparação de compostos de amina
DE60200535D1 (de) Verfahren zur Herstellung von hoch reinem Pemirolast
ATE424195T1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
DE60233064D1 (de) Analgetisches antitumorpeptid aus skorpionen und verfahren zu dessen herstellung
Nuţă et al. Synthesis, characterization and antimicrobial activity evaluation of new agents from benzamides class
DE602004025132D1 (de) Asymmetrische reduktive aminierung von ketosäurederivaten zur herstellung von aminosäurederivaten
BRPI0409012A (pt) processos para preparação de um produto reacional, de uma composição farmacêutica, de uma composição agroquìmica, de uma composição de limpeza, de uma composição de tinta e de um refrigerante ou lubrificante
DE602004015310D1 (de) Verfahren zur herstellung von mycophenolatmofetil
EP1142859A3 (en) Process for producing optically active 3,7-dimethyl-6-octenol and process for producing intermediate therefor
BRPI0409039A (pt) processo para a preparação de um produto de reação, processos para a preparação de uma composição farmacêutica, agroquìmica, de limpeza e de tinta, e processo para a preparação de um refrigerante
ITTO20030474A1 (it) Procedimento per la preparazione di dexloxiglumide
BR0312337A (pt) Derivados de ácido polienocarboxìlico, processo para a sua preparação e seu emprego
TH69582A (th) สารยับยั้งของฟอสฟาติดิลิโนซิทอล 3-ไคเนส
TH65934A (th) ยาซึ่งประกอบรวมด้วยบีทามิเมติค และแอนตีโคลิเนอร์จิคตัวใหม่

Legal Events

Date Code Title Description
FA Abandonment or withdrawal